eli lilly retatrutide is Lilly’s “Triple G”, A novel triple agonist for GIP, GLP1, and glucagon receptors., A 48 week phase 2 obesity study demonstrated 24.2% weight loss with retatrutide 12 mg with no Eli Lilly retatrutide Phase 3
Pay in 4 interest-free payments of $7.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29







:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)




















